Matches in SemOpenAlex for { <https://semopenalex.org/work/W2617493931> ?p ?o ?g. }
- W2617493931 endingPage "e338" @default.
- W2617493931 startingPage "e338" @default.
- W2617493931 abstract "TRPV4 belongs to the 'Transient Receptor Potential' (TRP) superfamily. It has been identified to profoundly affect a variety of physiological processes, including nociception, heat sensation and inflammation. Unlike other TRP superfamily channels, its role in cancers are unknown until recently when we reported TRPV4 to be required for cancer cell softness that may promote breast cancer cell extravasation and metastasis. Here, we elucidated the molecular mechanisms mediated by TRPV4 in the metastatic breast cancer cells. TRPV4-mediated signaling was demonstrated to involve Ca2+-dependent activation of AKT and downregulation of E-cadherin expression, which was abolished upon TRPV4 silencing. Functionally, TRPV4-enhanced breast caner cell transendothelial migration requires AKT activity while a combination of transcriptional and post-translational regulation contributed to the TRPV4-mediated E-cadherin downregulation. Finally, mass spectrometry analysis revealed that TRPV4 is required for the expression of a network of secreted proteins involved in extracellular matrix remodeling. In conclusion, TRPV4 may regulate breast cancer metastasis by regulating cell softness through the Ca2+-dependent AKT-E-cadherin signaling axis and regulation of the expression of extracellular proteins." @default.
- W2617493931 created "2017-06-05" @default.
- W2617493931 creator A5002985052 @default.
- W2617493931 creator A5010460040 @default.
- W2617493931 creator A5033388981 @default.
- W2617493931 creator A5034324809 @default.
- W2617493931 creator A5038503155 @default.
- W2617493931 creator A5039307487 @default.
- W2617493931 creator A5058481830 @default.
- W2617493931 creator A5068072983 @default.
- W2617493931 creator A5071235536 @default.
- W2617493931 creator A5082151152 @default.
- W2617493931 date "2017-05-22" @default.
- W2617493931 modified "2023-10-16" @default.
- W2617493931 title "TRPV4 plays a role in breast cancer cell migration via Ca2+-dependent activation of AKT and downregulation of E-cadherin cell cortex protein" @default.
- W2617493931 cites W1479840105 @default.
- W2617493931 cites W1533820435 @default.
- W2617493931 cites W1556575182 @default.
- W2617493931 cites W1833170350 @default.
- W2617493931 cites W1858610402 @default.
- W2617493931 cites W1912362810 @default.
- W2617493931 cites W1964064744 @default.
- W2617493931 cites W1965990651 @default.
- W2617493931 cites W1966133006 @default.
- W2617493931 cites W1967997862 @default.
- W2617493931 cites W1971156557 @default.
- W2617493931 cites W1977090021 @default.
- W2617493931 cites W1983988675 @default.
- W2617493931 cites W1988059242 @default.
- W2617493931 cites W1993232728 @default.
- W2617493931 cites W1996024251 @default.
- W2617493931 cites W1999521736 @default.
- W2617493931 cites W2009376981 @default.
- W2617493931 cites W2010928352 @default.
- W2617493931 cites W2011667027 @default.
- W2617493931 cites W2018730953 @default.
- W2617493931 cites W2019427642 @default.
- W2617493931 cites W2019696120 @default.
- W2617493931 cites W2021621741 @default.
- W2617493931 cites W2021958350 @default.
- W2617493931 cites W2024337967 @default.
- W2617493931 cites W2027491627 @default.
- W2617493931 cites W2030694827 @default.
- W2617493931 cites W2033354157 @default.
- W2617493931 cites W2033842010 @default.
- W2617493931 cites W2040512792 @default.
- W2617493931 cites W2045931277 @default.
- W2617493931 cites W2046372462 @default.
- W2617493931 cites W2052753918 @default.
- W2617493931 cites W2060308517 @default.
- W2617493931 cites W2061250729 @default.
- W2617493931 cites W2070086300 @default.
- W2617493931 cites W2070605762 @default.
- W2617493931 cites W2072706409 @default.
- W2617493931 cites W2076951847 @default.
- W2617493931 cites W2086277239 @default.
- W2617493931 cites W2092971609 @default.
- W2617493931 cites W2093116529 @default.
- W2617493931 cites W2093523276 @default.
- W2617493931 cites W2093829133 @default.
- W2617493931 cites W2096057003 @default.
- W2617493931 cites W2096065464 @default.
- W2617493931 cites W2109924796 @default.
- W2617493931 cites W2114270638 @default.
- W2617493931 cites W2114733179 @default.
- W2617493931 cites W2122341732 @default.
- W2617493931 cites W2122572948 @default.
- W2617493931 cites W2125372689 @default.
- W2617493931 cites W2128926964 @default.
- W2617493931 cites W2129688534 @default.
- W2617493931 cites W2138695033 @default.
- W2617493931 cites W2141260882 @default.
- W2617493931 cites W2157174760 @default.
- W2617493931 cites W2162071642 @default.
- W2617493931 cites W2164230236 @default.
- W2617493931 cites W2169774852 @default.
- W2617493931 cites W2170602872 @default.
- W2617493931 cites W2184801413 @default.
- W2617493931 cites W2328369945 @default.
- W2617493931 cites W2333026520 @default.
- W2617493931 cites W2419944446 @default.
- W2617493931 cites W332390835 @default.
- W2617493931 cites W4211102584 @default.
- W2617493931 doi "https://doi.org/10.1038/oncsis.2017.39" @default.
- W2617493931 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5523072" @default.
- W2617493931 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28530703" @default.
- W2617493931 hasPublicationYear "2017" @default.
- W2617493931 type Work @default.
- W2617493931 sameAs 2617493931 @default.
- W2617493931 citedByCount "78" @default.
- W2617493931 countsByYear W26174939312018 @default.
- W2617493931 countsByYear W26174939312019 @default.
- W2617493931 countsByYear W26174939312020 @default.
- W2617493931 countsByYear W26174939312021 @default.
- W2617493931 countsByYear W26174939312022 @default.
- W2617493931 countsByYear W26174939312023 @default.
- W2617493931 crossrefType "journal-article" @default.
- W2617493931 hasAuthorship W2617493931A5002985052 @default.